Ethanolamine kinase (EKI) is the first committed step in phosphatidylethanolamine (PtdEtn) biosynthesis via the CDP-ethanolamine pathway. We identify a human cDNA encoding an ethanolamine-specific kinase EKI1 and the structure of the EKI1 gene located on chromosome 12. EKI1 overexpression in COS-7 cells results in a 170-fold increase in ethanolamine kinase-specific activity and accelerates the rate of [ 3 H]ethanolamine incorporation into PtdEtn as a function of the ethanolamine concentration in the culture medium. Acceleration of the CDP-ethanolamine pathway does not result in elevated cellular PtdEtn levels, but rather the excess PtdEtn is degraded to glycerophosphoethanolamine. EKI1 has negligible choline kinase activity in vitro and does not influence phosphatidylcholine biosynthesis. Acceleration of the CDP-ethanolamine pathway also does not change the rate of PtdEtn formation via the decarboxylation of phosphatidylserine. The data demonstrate the existence of separate ethanolamine and choline kinases in mammals and show that ethanolamine kinase can be a rate-controlling step in PtdEtn biosynthesis.Ethanolamine kinase or EKI 1 (ATP:ethanolamine O-phosphotransferase, EC 2.7.1.82) catalyzes the first step of PtdEtn biosynthesis via the CDP-Etn pathway. ECT, a cytidylyltransferase, and EPT, an amino alcohol phosphotransferase, catalyze the subsequent two steps, and together these three enzymes constitute the de novo pathway for PtdEtn formation. The decarboxylation of PtdSer is an alternate route for PtdEtn production and is functionally important in cultured cell lines (1, 2), although the CDP-Etn pathway is considered a major route for PtdEtn synthesis in most mammalian tissues (3-6). PtdEtn is an abundant phospholipid in eucaryotic cell membranes, and the ECT reaction is thought to be a major regulator of its synthesis (7). EKI has been proposed as a regulatory step based on theoretical considerations (8). However, experimental investigations result in conflicting conclusions. Experiments performed with rat hepatocytes (4, 9) demonstrate that the supply of ethanolamine limits the rate of PtdEtn production at concentrations below 30 M. Only at higher concentrations of ethanolamine does accumulation of phosphoethanolamine occur, indicating ECT as the rate-limiting enzyme of the pathway. On the contrary, McMaster and Choy (10) report that the EKI step is rate-limiting with increased ethanolamine concentrations using a hamster heart perfusion model. Both studies agree that the rate of PtdEtn synthesis is dependent on the extracellular ethanolamine concentration (9, 10) and that the stimulation of PtdEtn biosynthesis occurs at physiological levels of 20 -50 M (9).There is a long standing discussion as to the number and specificity of the enzymes that catalyze the phosphorylation of ethanolamine and choline. In yeast, there are two enzymes that are able to phosphorylate choline and ethanolamine, and these enzymes are annotated based on their preferred substrate specificities. The CKI enzyme has a specific activit...